We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Canadian Guidance Clarifies Reconsideration Timelines
Canadian Guidance Clarifies Reconsideration Timelines
Pharma companies can expect to wait about 165 days for Health Canada to make a final decision on appeals of drug’s approval or rejection, according to April 1 guidance that sets specific timelines for every step of the dispute resolution process.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor